HHS nominee Azar declines to comment on Allergan patent move
HHS nominee Azar declines to comment on Allergan patent move Reuters Azar Opposes Abuse Of Drug Patents, REMS & Gag Orders; Open To Designing Part B Like Part D Inside Health Policy Full coverage